
    
      Randomized clinical trial comparing rates of RVR, eRVR, EOT and SVR during standard treatment
      with Pegylated Interferon-Alfa plus Ribavirin compared to the same treatment supplemented
      with B12 and vitamin D during the treatment period.

      Patients assigned to the vitamin supplementation group will receive the standard treatment of
      Pegylated Interferon-Alfa plus Ribavirin for 48 weeks together oral Vitamin D and
      intramuscular Vitamin B12. The control group will receive the same regimen of peguilated
      alfainterferon plus ribavirin for 48 weeks without any vitamin supplementation.
    
  